Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Sherratt

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ejhaem|August 19, 2024
Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: A case reportSam Sherratt-Mayhew, Phillip L R Nicolson
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 14, 2026
Unilateral red eye, consider short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearingSam Sherratt-Mayhew, Susan P Mollan, Mark Thaller
Eye (London, England)|July 16, 2025
Infographic: landmark trials in neuro-ophthalmology - results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathySam Sherratt-Mayhew, Charles Page, Gabriele Berman, et al.
Cureus|June 5, 2026
The Efficacy of Nicotinamide in Maintaining Mean Deviation in Glaucoma: A Systematic ReviewSam Sherratt-Mayhew, Max Bisp, Charles Page, et al.
Eye (London, England)|August 26, 2025
Infographic: Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset (RESCUE Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|February 5, 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|September 19, 2025
Infographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trialSam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Frontiers in Immunology|October 12, 2016
Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell FunctionMartin R Goodier, Chiara Lusa, Sam Sherratt, et al.
BMJ Open Ophthalmology|June 15, 2026
A systematic review of neuroprotective therapies for visual acuity preservation in retinitis pigmentosaSam Sherratt-Mayhew, Max Bisp, Sanna Waheed, et al.
JMIR Medical Education|June 17, 2026
Co-Designing and Evaluating a 1-Day Quality Improvement Workshop for Medical Students and Resident Physicians: Tutorial on Applying Kern's Curriculum Development FrameworkAmanda Ling Jie Yee, Mariam Idrissi, Sam Sherratt-Mayhew, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ejhaem|August 19, 2024
Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: A case reportSam Sherratt-Mayhew, Phillip L R Nicolson
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 14, 2026
Unilateral red eye, consider short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearingSam Sherratt-Mayhew, Susan P Mollan, Mark Thaller
Eye (London, England)|July 16, 2025
Infographic: landmark trials in neuro-ophthalmology - results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathySam Sherratt-Mayhew, Charles Page, Gabriele Berman, et al.
Cureus|June 5, 2026
The Efficacy of Nicotinamide in Maintaining Mean Deviation in Glaucoma: A Systematic ReviewSam Sherratt-Mayhew, Max Bisp, Charles Page, et al.
Eye (London, England)|August 26, 2025
Infographic: Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset (RESCUE Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|February 5, 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|September 19, 2025
Infographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trialSam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Frontiers in Immunology|October 12, 2016
Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell FunctionMartin R Goodier, Chiara Lusa, Sam Sherratt, et al.
BMJ Open Ophthalmology|June 15, 2026
A systematic review of neuroprotective therapies for visual acuity preservation in retinitis pigmentosaSam Sherratt-Mayhew, Max Bisp, Sanna Waheed, et al.
JMIR Medical Education|June 17, 2026
Co-Designing and Evaluating a 1-Day Quality Improvement Workshop for Medical Students and Resident Physicians: Tutorial on Applying Kern's Curriculum Development FrameworkAmanda Ling Jie Yee, Mariam Idrissi, Sam Sherratt-Mayhew, et al.
Pageof 2